Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Shares Outstanding (Diluted Average): 2019-2024

Historic Shares Outstanding (Diluted Average) for Bicycle Therapeutics (BCYC) over the last 6 years, with Dec 2024 value amounting to $58.2 million.

  • Bicycle Therapeutics' Shares Outstanding (Diluted Average) rose 0.46% to $69.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year increase of 0.46%. This contributed to the annual value of $58.2 million for FY2024, which is 63.54% up from last year.
  • As of FY2024, Bicycle Therapeutics' Shares Outstanding (Diluted Average) stood at $58.2 million, which was up 63.54% from $35.6 million recorded in FY2023.
  • Over the past 5 years, Bicycle Therapeutics' Shares Outstanding (Diluted Average) peaked at $58.2 million during FY2024, and registered a low of $19.1 million during FY2020.
  • For the 3-year period, Bicycle Therapeutics' Shares Outstanding (Diluted Average) averaged around $41.2 million, with its median value being $35.6 million (2023).
  • Data for Bicycle Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY surged of 73.34% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Bicycle Therapeutics' Shares Outstanding (Diluted Average) stood at $19.1 million in 2020, then soared by 30.90% to $25.1 million in 2021, then climbed by 18.35% to $29.7 million in 2022, then grew by 20.00% to $35.6 million in 2023, then surged by 63.54% to $58.2 million in 2024.